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movements (6), this infection was considered to be autoch-
thonous, indicating endemicity of the C. gattii VGIIb-like 
variant in Nova Scotia and highlighting the value of non-
migratory animals as sentinels for emerging diseases (7). 
Incidence for this disease is highest in the Pacific North-
west, where the primary agents are C. gattii VGII geno-
types (2,4). A pertinent literature review and consultation 
with regional public and veterinary health authorities de-
termined that Québec was the most eastern province in 
Canada where crytococcosis associated with C. gattii VGII 
has caused clinical disease that was not potentially travel 
related in humans (Phillippe Dufresne, pers. comm.). In 
eastern North America, the C. gattii VGIIb genotype is re-
ported to have caused disseminated cryptococcosis in a hu-
man in Florida, USA (8,9). Because C. gattii is potentially 
pervasive in the environment, the Nova Scotia Department 
of Health has alerted provincial infectious disease special-
ists and the provincial public health laboratory to ensure 
availability of the diagnostic capacity to test for the fungus. 
The C. gattii VGIIb genotype causes substantial, life-
threatening disease in otherwise healthy hosts (2), and a 
unique VGIIb-like variant is endemic to Atlantic Canada. 
Therefore, continued surveillance by physicians and veteri-
narians in the region is warranted.
Acknowledgments
We thank Beatrice Despres for her technical support in the  
operation and maintenance of matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry for sample  
analysis. We also thank Bob Petri and Donald Sam for their 
ongoing support of the scanning wildlife health surveillance 
program in Atlantic Canada and encouragement of Nova Scotia 
Department of Natural Resources field staff to take the time and 
make the effort to submit diagnostic specimens from the white-
tailed deer, enabling a confirmatory diagnosis for this index case 
of cryptococcosis in Atlantic Canada.
The cost of the diagnostic testing for this case was covered by 
the scanning wildlife health surveillance program of the  
Canadian Wildlife Health Cooperative. 
References
  1. Lester SJ, Malik R, Bartlett KH, Duncan CG. Cryptococcosis: 
update and emergence of Cryptococcus gattii. Vet Clin Pathol. 
2011;40:4–17. http://dx.doi.org/10.1111/j.1939-165X.2010.00281.x
  2. Espinel-Ingroff A, Kidd SE. Current trends in the prevalence of 
Cryptococcus gattii in the United States and Canada. Infect Drug 
Resist. 2015;8:89–97. http://dx.doi.org/10.2147/IDR.S57686
  3. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR,  
Esposto MC, et al. Consensus multi-locus sequence typing  
scheme for Cryptococcus neoformans and Cryptococcus gattii.  
J Med Mycol. 2009;47:561–70. http://dx.doi.org/10.1080/ 
13693780902953886
  4. Byrnes EJ, Li W, Lewit Y, Ma H, Voelz K, Ren P, et al. Emergence 
and pathogenicity of highly virulent Cryptococcus gattii genotypes 
in the Northwest United States. PLoS Pathog. 2010;6:e1000850.  
http://dx.doi.org/10.1371/journal.ppat.1000850
  5. Engelthaler DM, Hicks ND, Gillece JD, Roe CC, Schupp JM, 
Driebe EM, et al. Cryptococcus gattii in North America Pacific 
Northwest: whole-population genome analysis provides insights 
into the species evolution and dispersal. mBiol. 2014; 5:e01464–
14. http://dx.doi.org/10.1128/mBio.01464-14
  6. Marchinton Rl, Hirth DH. Chapter 6: Behavior. In: Halls LK,  
editor. White-tailed deer: ecology and management. Harrisburg 
(PA): Stackpole Books; 1984. p. 129–68.
  7. Duncan C, Schwantje H, Stephen C, Campbell J, Bartlett K. 
Cryptococcus gattii in wildlife of Vancouver Island, British 
Columbia, Canada. J Wildl Dis. 2006;42:175–8. http://dx.doi.org/ 
10.7589/0090-3558-42.1.175
  8. Kunadharaju R, Choe U, Harris JR, Lockhart SR, Greene JN. 
Cryptococcus gattii, Florida, USA, 2011. Emerg Infect Dis. 
2013;19:519–21. http://dx.doi.org/10.3201/eid1903.121399
  9. Lockhart SR, Iqbal N, Harris JR, Grossman NT, DeBess E,  
Wohrle R, et al. Cryptococcus gattii in the United States:  
genotypic diversity of human and veterinary isolates. PLoS ONE. 
2013;8:e74737 http://dx.doi.org/10.1371/journal.pone.0074737.
Address for correspondence: David P. Overy, Department of Pathology 
and Microbiology, Atlantic Veterinary College, University of Prince 
Edward Island, 550 University of Prince Edward Island, Charlottetown, 
PEI, Canada; email: dovery@upei.ca
Zika Virus in a Traveler  
Returning to China from  
Caracas, Venezuela,  
February 2016
Jiandong Li,1 Ying Xiong,1 Wei Wu,1  
Xiaoqing Liu,1 Jing Qu, Xiang Zhao, Shuo Zhang, 
Jianhua Li, Weihong Li, Yong Liao, Tian Gong, 
Lijing Wang, Yong Shi, Yanfeng Xiong, Daxin Ni, 
Qun Li, Mifang Liang, Guoliang Hu, Dexin Li
Author affiliations: National Institute for Viral Disease Control and 
Prevention, Chinese Center for Disease Control and Prevention, 
Beijing, China (Jiandong Li, W. Wu, J. Qu, X. Zhao, S. Zhang,  
L. Wang, M. Liang, D. Li); Jiangxi Provincial Center for Disease 
Control and Prevention, Nanchang, China (Y. Xiong, X. Liu,  
T. Gong, Y. Shi, G. Hu); Ganzhou Municipal Center for Disease 
Control and Prevention, Ganzhou, China (Jianhua Li, Y. Liao,  
Y. Xiong); Office of Emergence Response, Chinese Center for 
Disease Control and Prevention, Beijing (D. Ni, Q. Li); Beijing 
Center for Disease Prevention and Control, Beijing (W. Li)
DOI: http://dx.doi.org/10.3201/eid2206.160273
To the Editor: Zika virus, a member of the Flaviviri-
dae family, is primarily transmitted through Aedes spp. 
mosquitoes, and evidence of vertical, sexual, and blood 
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transmission of Zika virus has been reported (1–3). The 
virus has spread rapidly across Latin America and the Ca-
ribbean since the end of 2014 and has been linked to an in-
crease in neurologic disorders and neonatal malformations 
in these areas (4). Zika virus has the potential to spread 
internationally through the carriage of goods and travelers 
(5). Traveler volume between China and areas with autoch-
thonous transmission of Zika virus is increasing; in 2015, 
China received ≈84,000 travelers who had departed from 
international airports in Brazil (5). The Ae. aegypti mosqui-
to, the competent vector for Zika virus, is found in areas of 
Hainan, Guangdong, and Yunnan provinces on the mainland 
of China, where the known distribution is limited to areas 
below 22° latitude. However, Ae. albopictus mosquitoes are 
widely distributed, extending from the southern reaches to 
the northern and western parts of China, with north fringes 
from Shenyang in Liaoning Province, through Tianshui and 
Longnan in Gansu Province, to Motuo in Tibet (6). Surveil-
lance of Zika virus infection among Chinese travelers has 
been enhanced since January 2016. We report the clinical 
and laboratory findings for a case Zika virus infection im-
ported from Venezuela.
A previously healthy 34-year-old Chinese man was 
admitted to the Hospital of Ganxian on February 6, 2016. 
He had worked in Caracas, Venezuela, during January 1–
February 2 and had onset of fever (38.0°C), headache, and 
1134 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 22, No. 6, June 2016
LETTERS
Figure. Phylogenetic analysis of partial sequences of Zika virus for an imported case of Zika virus infection in a traveler returning to 
China from Caracas, Venezuela, February 2016, compared with selected other strains from GenBank. A) Schematic diagram showing 
the contiguous sequence, obtained from de novo assembly and BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi), targeted at the 3′ 
terminus of nonstructural protein 2B and the 5′ terminus of nonstructural protein 3 genes (figure not drawn to scale). B) Maximum-
likelihood phylogenetic tree inferred based on the Tamura-Nei model (8). The partial sequence of VE_Ganxian (black dot) obtained in 
this study was analyzed against 11 reference strains of Asian lineage and 5 reference strains of African lineage. All positions containing 
gaps and missing data were eliminated. Evolutionary analyses were conducted in MEGA version 7.0 (http://www.megasoftware.
net). GenBank accession numbers are given. Scale bar indicates number of substitutions per site. C, capsid; E, envelope; MTase, 
methyltransferase; PrM, premembrane; RdRP, RNA-dependent RNA polymerase.
dizziness on January 28. He subsequently had rash, chills, 
retro-orbital pain, and mild diarrhea on February 2, the day 
on which he departed from Caracas and traveled to Jiangxi 
Province via Paris and Hong Kong, arriving in Shenzhen, 
China, on February 5. At the time of hospital admission, the 
patient had fever (36.7°C), headache, conjunctivae, rash on 
his back and face, retro-orbital pain, and mild diarrhea. 
General clinical examination was unremarkable. Results of 
a complete blood cell count and liver function tests were 
within reference ranges.
Serum samples were collected at day 9 and day 10 af-
ter symptom onset, and urine samples were collected once 
a day from day 10 through day 14. In the 2 serum samples, 
no dengue virus (DENV) or chikungunya virus (CHIKV) 
IgM or IgG were detected by a Panbio IgM and IgG cap-
ture ELISA for DENV (Panbio, Queensland, Australia) or 
by an indirect immunofluorescence assay slide test kit for 
CHIKV (EUROIMMUN AG, Lübeck, Germany). Serum 
and urine samples were negative for DENV nonstructural 
protein 1 (NS1) antigen on an NS1-ELISA test kit (Want-
ai Bio-Pharm, Beijing, China). To detect virus RNA in 
samples, in-house–designed probe and primers specific to 
DENV and CHIKV were used (7). The PCR for Zika virus 
was targeted to the NS1 gene. RNA was extracted from 140 
μL of serum or urine by using the QIAamp Viral RNA Mini 
Kit (QIAGE, Hilden, Germany). Amplification reactions 
were performed by using the AgPath-ID One-Step RT-PCR 
Kit (Ambion, Carlsbad, CA, USA). A standard curve with 
serial dilutions of known concentrations of in vitro–tran-
scribed RNA from a reference plasmid was used to estimate 
viral load in samples. Test results for DENV and CHIKV 
were negative. However, the serum sample collected at day 
9 was positive for Zika virus RNA (viral load 1.4 × 104 
copies/mL), and Zika virus RNA was detected from urine 
samples collected on days 10, 11, and 12 (viral loads 8.6 × 
104, 4.5 × 104, and 1.2 × 104 copies/mL, respectively).
Next-generation genomic sequencing of the Zika virus 
genome was conducted by using the MiSeq platform (Il-
lumina, Hayward, CA, USA) on serum and urine samples. 
A 1,813-bp of partial genome sequences (strain VE_Ganx-
ian, GenBank accession no. KU740199) was obtained 
from urine and was used for comparing with selected other 
strains from GenBank. Phylogenetic analysis showed that 
the virus was of Asian lineage (Figure). Pairwise genetic 
distance calculation indicated that the sequence was most 
closely related to other viruses reported from French Poly-
nesia in 2013 (strain H/PF/2013), the Caribbean in 2014 
(strain Haiti/1225/2014), and Latin America in 2015 (strain 
ZikaSPH2015), having a 99.4% similarity in sequence.
The clinical findings for the patient were similar to 
those previously reported among Zika virus–infected pa-
tients (9), although no arthralgia was apparent. Viral RNA 
remained detectable for 9 days after symptom onset in 
serum and for an additional 3 days in urine. We did not test 
this patient’s semen and thus cannot comment on risk for 
onward sexual transmission; however, the patient was told 
about the risks for sexual transmission of Zika virus and 
was advised to adopt safer sexual practices or to abstain 
from sexual activity for at least 1 month after recovery. In 
February, the mosquito density is low in Jiangxi Province 
(10), suggesting that this imported case is unlikely to cause 
mosquitoborne transmission. However, with the onset of 
summer and increased density of Aedes mosquitos, the risk 
for onward transmission of travel-associated Zika virus 
should not be overlooked.
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To the Editor: Invasive meningococcal disease is 
usually defined by the occurrence of meningitis or sep-
ticemia. Pericarditis might occur during the course of 
invasive infection. This clinical picture, defined as dis-
seminated meningococcal disease with pericarditis (1) 
or secondary meningococcal pericarditis, was reported 
in 1918 (2). In 1939, primary or isolated meningococcal 
pericarditis (1,3) was described. In this form of pericar-
ditis, pericardial or blood cultures are positive for Neis-
seria meningitidis but there is no meningeal involvement 
or clinical meningococcemia (4).
Since its description, several cases of primary menin-
gococcal pericarditis have been reported (5). Although its 
pathogenesis remains largely undefined, it has been hy-
pothesized that the onset of primary pericarditis occurs 
after a transient bacteremia or as a consequence of involve-
ment of the lower respiratory tract (4). Blaser et al. reported 
that serogroup C meningococci are usually associated with 
this disease, especially in adults. However, serogroups B, 
W, and Y have also been identified (4). We report a case-
patient with primary meningococcal pericarditis caused by 
a serogroup C strain of N. meningitidis.
The patient was a 32-year-old man who lived in Sar-
dinia, Italy. He had no predisposing factors, such as im-
munodeficiency or other chronic disorders. Disease onset 
occurred on August 29, 2015. Clinical manifestations were 
fever (temperature 38°C), hypotension, epigastralgia, ar-
thralgia, asthenia, chest pain, and reduced vesicular mur-
mur. The left ventricle was widely hypokinetic, and a light 
ST increase was observed. A blood culture was positive for 
N. meningitidis.
The patient was given piperacillin/tazobactam (4.5 g 
3×/d) and metronidazole (500 mg 3×/d) for 4 days. After 4 
days, treatment with ceftriaxone (2 g 2×/d) for 4 days was 
started. Because of persistent fever (38.8°C), levofloxacin 
(500 mg 2×/d) for 23 days was also started on day 7. On 
day 10, ceftriaxone was replaced with piperacillin/tazobac-
tam (4.5 g 4×/d) for 21 days. A major bilateral pleural effu-
sion was detected on the left side. On day 11, the fever had 
resolved. The outcome was favorable for this patient.
Drug resistance of the strain was determined by us-
ing the MIC Test Strip Method (Liofilchem, Abruzzi, Italy). 
Breakpoints used were those recommended by the Europe-
an Committee on Antimicrobial Susceptibility Testing ver-
sion 5.0 (http://www.eucast.org/). The strain was suscep-
tible to cefotaxime, ceftriaxone, ciprofloxacin, penicillin G, 
and rifampin. Serogroup was determined by using slide ag-
glutination with commercial antisera (Remel Europe, Ltd., 
Dartford, UK) and confirmed by PCR (6).
Whole-genome sequencing was conducted to obtain 
molecular data and enable comparison with other me-
ningococci of the same serogroup that were isolated in 
Italy. Multilocus sequence typing (MLST) and typing of 
porA and fetA genes and Bexsero (meningococcal group 
B vaccine) antigen genes (http://www.fda.gov/Biologics 
BloodVaccines/Vaccines/ApprovedProducts/ucm431374.
htm) were conducted as described (http://neisseria.org/). 
Whole-genome sequence was analyzed by using the 
BIGSdb Genome Comparator Tool (http://pubmlst.org/ 
neisseria/). Genomes of meningococci belonging to the 
same finetype were compared by using the core genome 
MLST (cgMLST) approach.
The N. meningitidis strain of serogroup C was suscep-
tible to all antimicrobial drugs tested. Although serogroup 
C was associated with 53 (41%) of 132 invasive menin-
gococcal disease cases in Italy in 2015 (http://www.iss.it/
binary/mabi/cont/Report_MBI_20151223_v4.pdf), this se-
rogroup has not been detected in Sardinia since 2010.
Molecular analyses showed that the strain belonged 
to the hypervirulent clonal complex (cc) 11, sequence type 
(ST) 11. The complete finetype was C:5–1,10–8:F3–6:ST-
11(cc11). This finetype has been reported in the United 
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